全文获取类型
收费全文 | 1646篇 |
免费 | 88篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 27篇 |
妇产科学 | 11篇 |
基础医学 | 258篇 |
口腔科学 | 29篇 |
临床医学 | 109篇 |
内科学 | 401篇 |
皮肤病学 | 12篇 |
神经病学 | 115篇 |
特种医学 | 26篇 |
外科学 | 381篇 |
综合类 | 5篇 |
预防医学 | 36篇 |
眼科学 | 16篇 |
药学 | 152篇 |
中国医学 | 4篇 |
肿瘤学 | 148篇 |
出版年
2023年 | 16篇 |
2022年 | 8篇 |
2021年 | 37篇 |
2020年 | 23篇 |
2019年 | 36篇 |
2018年 | 37篇 |
2017年 | 19篇 |
2016年 | 26篇 |
2015年 | 28篇 |
2014年 | 37篇 |
2013年 | 56篇 |
2012年 | 74篇 |
2011年 | 80篇 |
2010年 | 43篇 |
2009年 | 36篇 |
2008年 | 75篇 |
2007年 | 86篇 |
2006年 | 95篇 |
2005年 | 70篇 |
2004年 | 70篇 |
2003年 | 70篇 |
2002年 | 66篇 |
2001年 | 58篇 |
2000年 | 47篇 |
1999年 | 47篇 |
1998年 | 22篇 |
1997年 | 22篇 |
1996年 | 24篇 |
1995年 | 17篇 |
1994年 | 14篇 |
1993年 | 14篇 |
1992年 | 46篇 |
1991年 | 25篇 |
1990年 | 35篇 |
1989年 | 26篇 |
1988年 | 26篇 |
1987年 | 41篇 |
1986年 | 24篇 |
1985年 | 22篇 |
1984年 | 10篇 |
1983年 | 18篇 |
1982年 | 11篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1976年 | 7篇 |
1975年 | 10篇 |
1974年 | 11篇 |
1973年 | 10篇 |
1970年 | 10篇 |
1967年 | 9篇 |
排序方式: 共有1748条查询结果,搜索用时 31 毫秒
21.
The results of surgical treatment for a ruptured type B aortic dissection remain far from satisfactory. It is believed that
additional perfusion from the right axillary artery might be more beneficial than perfusion from only the femoral artery during
surgery for a ruptured thoracic aneurysm. The right axillary perfusion is more likely to perfuse the vital organs proximal
to the ruptured area, and thus avoid retrograde emboli. In addition, if the open proximal method is performed, then the right
axillary perfusion is able to facilitate the evacuation of air from the aortic lumen. We present herein the case of a patient
in whom a ruptured type B acute aortic dissection was successfully treated by applying right axillary perfusion through a
left thoracotomy. 相似文献
22.
23.
24.
25.
Matsumoto G Sunamura M Shimamura H Kodama T Hashimoto W Kobari M Kato K Takeda K Yagita H Okumura K Hamada H Matsuno S 《Surgery》1999,125(3):257-264
BACKGROUND: To explore effective therapeutic strategy against cancer of the gastrointestinal tract, tumor vaccination using fibroblasts secreting interleukin-12 (IL-12) was developed as an adjuvant therapy against murine tumor after surgical resection. METHODS: Initially, IL-12 was genetically engineered into fibroblasts (IL-12/3T3 cells), and then we evaluated in vivo and in vitro antitumor effects. In the vaccination model, irradiated C-26 tumor mass was reinoculated intradermally with IL-12/3T3 cells in mice as a tumor vaccine to examine how much it suppresses tumor recurrence. RESULTS: IL-12/3T3 cells producing 7.2 ng/10(6) cells/24 h murine IL-12 in vitro exerted dose-dependent potent tumor suppression when coinoculated with C-26 cells in vivo. Specific immunity was also acquired in 63% of mice in vivo. In the vaccination model, protective immunity was developed in 70% of mice that were inoculated with irradiated tumor mass and IL-12/3T3 cells. In addition, local recurrence was not observed in vaccinated mice, although 44% of control mice had recurrence. CONCLUSIONS: Coinoculation of genetically engineered fibroblasts secreting IL-12 with irradiated tumor mass was proved to be an effective tumor vaccine. This system of vaccination is easily applicable to clinical situations, particularly to human gastrointestinal tract cancers. 相似文献
26.
27.
Ezaki O Takahashi M Shigematsu T Shimamura K Kimura J Ezaki H Gotoh T 《Journal of nutritional science and vitaminology》1999,45(6):759-772
Although important roles of dietary n-3 fatty acids in the prevention of coronary heart disease (CHD) have been suggested, long-term effects of dietary alpha-linolenic acid (ALA, 18:3n-3) have not yet been established under controlled conditions. We tested whether a moderate increase of dietary ALA affects fatty acids composition in serum and the risk factors of CHD. Oxidized LDL (OxLDL) was directly measured by ELISA using antibody specific to OxLDL. By merely replacing soybean cooking oil (SO) with perilla oil (PO) (i.e., increasing 3 g/d of ALA), the n-6/n-3 ratio in the diet was changed from 4:1 to 1:1. Twenty Japanese elderly subjects were initially given a SO diet for at least 6 mo (baseline period), a PO diet for 10 mo (intervention period), and then returned to the previous SO diet (washout period). ALA in the total serum lipid increased from 0.8 to 1.6% after 3 mo on the PO diet, but EPA and DHA increased in a later time, at 10 mo after the PO diet, from 2.5 to 3.6% and 5.3 to 6.4%, respectively (p<0.05), and then returned to baseline in the washout period. In spite of increases of serum n-3 fatty acids, the OxLDL concentration did not change significantly when given the PO diet. Body weight, total serum cholesterol, triacylglycerol, glucose, insulin and HbA1c concentrations, platelet count and aggregation function, prothrombin time, partial thromboplastin time, fibrinogen and PAI-1 concentration, and other routine blood analysis did not change significantly when given the PO diet. These data indicate that, even in elderly subjects, a 3 g/d increase of dietary ALA could increase serum EPA and DHA in 10 mo without any major adverse effects. 相似文献
28.
Y Murakami H Hara T Okada H Hashizume M Kii Y Ishihara M Ishikawa M Shimamura S Mihara G Kato K Hanasaki S Hagishita M Fujimoto 《Journal of medicinal chemistry》1999,42(14):2621-2632
A novel series of potent and selective non-peptide neuropeptide Y (NPY) Y1 receptor antagonists, having benzazepine nuclei, have been designed, synthesized, and evaluated for activity. Chemical modification of the R(1) and R(3) substituents in structure 1 (Chart 1) yields several compounds that show high affinity for the Y1 receptor (K(i) values of less than 10 nM). SAR studies revealed that introduction of an isopropylurea group at R(1) and a 3-(benzo-condensed-urea) group, 3-(fluorophenylurea) group, or a 3-(N-(4-hydroxyphenyl)guanidine) group at R(3) in structure 1 afforded potent and subtype-selective NPY Y1 receptor antagonists. 3-(3-(Benzothiazol-6-yl)ureido)-1-N-(3-(N'-(3-isopropylureido++ +))benzyl )-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one (21), which was one of the most potent derivatives, competitively inhibited specific [(125)I]peptide YY (PYY) binding to Y1 receptors in human neuroblastoma SK-N-MC cells (K(i) = 5.1 nM). 21 not only inhibited the Y1 receptor-mediated increase in cytosolic free Ca(2+) concentration in SK-N-MC cells but also antagonized the Y1 receptor-mediated inhibitory effect of peptide YY on gastrin-induced histamine release in rat enterochromaffin-like cells. 21 showed no significant affinity in 17 receptor binding assays including Y2, Y4, and Y5 receptors. 相似文献
29.
We report the case of primary hepatic carcinoid tumor of which diagnosis was made by fine needle biopsy of a liver mass. The patient was treated successfully by left hepatic trisegmentectomy. This patient presented with complaints of generalized fatigue, but denied the presence of flushing, diarrhea, or other endocrine symptoms. Physical examination was unremarkable. A biopsy specimen revealed Grimelius stained cells that were immunoreactive for chromogranin A. Careful pre- and intraoperative examinations revealed no other primary lesions. Argyrophilia of the tumor cells suggested that the tumor was of fore five cases of primary hepatic carcinoid tumors previously reported in the literature are also reviewed. 相似文献
30.
Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression. 总被引:5,自引:0,他引:5
Takeshi Shimamura Michiie Sakamoto Yoshinori Ino Yasuto Sato Kazuaki Shimada Tomoo Kosuge Hisahiko Sekihara Setsuo Hirohashi 《Journal of clinical oncology》2003,21(4):659-667
PURPOSE: The E-cadherin-mediated cell adhesion system is frequently inactivated by multiple mechanisms and is involved in tumor progression in many types of cancer. Recently, we reported the cloning and characterization of dysadherin and showed that it downregulated E-cadherin and promoted metastasis. The aim of this study was to investigate the clinical significance of dysadherin expression and the relationship between dysadherin expression and E-cadherin expression in pancreatic ductal adenocarcinoma. PATIENTS AND METHODS: We examined dysadherin and E-cadherin expression in 125 surgically resected pancreatic ductal adenocarcinoma patients using immunohistochemistry. RESULTS: Dysadherin was expressed at the cell membrane of cancer cells, but not in nontumor duct and acinar cells. Its expression was stronger in infiltrative and poorly differentiated nests compared with well-differentiated nests. Although the correlation between the expression of dysadherin and E-cadherin was not significant, a group of patients showed reduced E-cadherin expression with dysadherin overexpression. Increased dysadherin expression was significantly correlated with distant metastasis (P =.047), high tumor grade (P =.006), positive tumor margins (P =.024), and infiltrative type of growth pattern (P =.014). A survival advantage was observed in patients with 0% to 20% dysadherin-positive cells compared with patients with 51% to 100% dysadherin-positive cells, independent of tumor-node-metastasis classification, and World Health Organization tumor grade (P =.019). A combination of increased dysadherin expression and reduced E-cadherin expression (< 90%) further worsened the prognosis. CONCLUSION: In pancreatic ductal adenocarcinoma, dysadherin expression seems to reflect tumor aggressiveness and to be a positive marker of poor prognosis when considered both alone and in combination with downregulation of E-cadherin. 相似文献